Diagnosis and management of non-dialysis chronic kidney disease in ambulatory care: a systematic review of clinical practice guidelines

Table 10 Recommendation summary - other subjects

other subjects		CEBAM	ACP	HAS	KDIGO	KHA-CARI	BCMA	UMHS	VA-DoD	NICE
other subjects		2012	2013	2013	2013	2013	2014	2014	2014	2015
patient education		▪				▪			▪	▪
diet	protein intake (in g/kg/day)				0.8	0.75–1.0			0.6–0.8
	no low protein diet < 0.6 g/kg/day					▪				▪
complications	CKD-mineral bone disorder	▪			▪		▪	▪		▪
diabetes	HbA1c target values (in %)				7.0				< 7.0
	metformin	with caution					avoid/reduce
	cardiovascular risk					▪
hyperlipidemia					➢					➢
	statins for cardiovascular risk				i			i
	statins for CKD progression								–
	ezetimibe							i
congestive heart failure		▪			▪
antigoagulants and antiplatelets		▪			▪	▪				▪
nephrotoxic Medication	geneneral				–			–
	NSAID									–
vaccinations									▪
metabolism	hyperuricemia				▪					▪
	oral bicarbonate				▪				▪	▪
nephrotoxic medication			▪					▪		▪

▪ recommendation, − negative recommendation, i: when indicated, ➢ referral to KDIGO and NICE guidelines on lipid management, CKD chronic kidney disease, HbA1c glycated Hemoglobin, NSAID nonsteroidal anti-inflammatory drugs
American College of Physicians (ACP), Belgisch Centrum voor Evidence Based Medicine (CEBAM), British Columbia Medical Association (BCMA), Department of Veteran’s Affairs (VA-DoD), Haute Autorité de Santé (HAS), Kidney Disease Improving Global Outcomes (KDIGO), Kidney Health Australia - Caring for Australasiansians with Renal Impairment (KHA-CARI), National Institute of Health and Care Excellence (NICE), University of Michigan Health System (UMHS)

ISSN: 1471-2369